Unproven Stem Cell Therapy for Autism Treatment
The Union Ministry of Health & Family Welfare (2026) issued an advisory to restrict unproven stem cell interventions, including for Autism Spectrum Disorder, clarifying it is not approved as routine care and permitted only in approved clinical trials under National Guidelines for Stem Cell Research, 2017 (ICMR-DBT). Pursuant to Supreme Court judgment in Yash Charitable Trust v Union of India, violations may invite IMC Regulations, 2002 (Reg. 7.22) action and penalties under Clinical Establishments Act, 2010 (Sections 32, 40); State Medical Councils to investigate and discipline.
PIB

